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A cross-sectional study was performed to investigate the prevalence and predictors of
suicidal ideation and past suicide attempt in an Australian sample of human imumuno-
deficiency virus (HIV)-positive and HIV-negative homosexual and bisexual men. Sixty-
five HIV-negative and 164 HIV-positive men participated. A suicidal ideation score was
derived from using five items selected from the Beck Depression Inventory and the Gen-
eral Health Questionnaire (28-item version). Lifetime and current prevalence rates of
psychiatric disorder were evaluated with the Diagnostic Interview Schedule
Version-III-R. The HIV-positive (Centers for Disease Control and Prevention [CDC]
Stage IV) men (n485) had significantly higher total suicidal ideation scores than the
asymptomatic HIV-positive men (CDC Stage II/III) (n479) and the HIV-negative men.
High rates of past suicide attempt were detected in the HIV-negative (29%) and
HIV-positive men (21%). Factors associated with suicidal ideation included being HIV-
positive, the presence of current psychiatric disorder, higher neuroticism scores, external
locus of control, and current unemployment. In the HIV-positive group analyzed sepa-
rately, higher suicidal ideation was discriminated by the adjustment to HIV diagnosis
(greater hopelessness and lower fighting spirit), disease factors (greater number of cur-
rent acquired immunodeficiency syndrome [AIDS]-related conditions), and background
variables (neuroticism). Significant predictors of a past attempted suicide were a posi-
tive lifetime history of psychiatric disorder (particularly depression diagnoses), a life-
time history of injection drug use, and a family history of suicide attempts. The findings
indicate increased levels of suicidal ideation in symptomatic HIV-positive men and high-
light the role that multiple psychosocial factors associated with suicidal ideation and
attempted suicide play in this population. (Psychosomatics 1998; 39:405–415)
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Suicide, attempted suicide, and suicidal ide-ation are complex clinical issues associated
with life-threatening conditions such as human
immunodeficiency virus (HIV) infection. Sui-
cide in persons with HIV infection/acquired im-
munodeficiency syndrome (AIDS) has been re-
ported in most cases to be associated with a
conncomitant psychiatric disorder.1 The risk of
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suicide may extend to those fearful of contract-
ing HIV infection2,3 as well as the family and
partners of those infected.4 Elevated lifetime
rates of affective disorders (particularly major
depression) and substance use disorders have
been reported in studies of HIV-positive men.5–7
Further, certain patterns of behavior associated
with the risk of acquiring HIV infection (e.g.,
injection drug use) may be associated with
higher rates of suicidal ideation and psychiatric
disorder.8
Patterns of attempted suicide and suicidal
thoughts may differ throughout the progression
of HIV infection. There are at least two high-
risk periods: 1) the initial 6 months after diag-
nosis of infection with HIV and 2) the onset of
physical complications of AIDS.9–11 The period
of greatest risk may be within the first 3 months
of diagnosis (one study reported that over 40%
of the men in one cohort who were HIV-positive
had attempted suicide within this 3-month pe-
riod9). HIV-positive persons who are asymptom-
atic or have early HIV-related disease may
experience higher rates of suicidal ideation com-
pared with persons with AIDS.11,12 A history of
alcohol abuse, other drug dependence, major de-
pression, past suicide attempts, and diagnosis of
a personality disorder have also been associated
with suicide risk.12 A longer duration of HIV
infection,13 the onset of acute illness, and be-
reavement are also factors that may increase sui-
cide risk, as well as stigma, social isolation, the
perception of poor social support, and occur-
rence of HIV-related occupational and interper-
sonal problems.10,13
In a study of U.S. national suicide data from
1987–1989,14 a suicide rate of 165 per 100,000
person years of observation was calculated for
individuals with AIDS, a rate 7.4 times higher
than demographically similar individuals in the
general population. However, while still high,
this figure was a decrease in the suicide rate
among individuals with AIDS over the 1987–
1989 period, leading the authors to speculate
about the roles that better psychiatric care, newer
therapies for HIV, and a possible lessening of
social adversity and stigma faced by HIV-
positive men may have played in this decrease.
The aim of this study, conducted between
1989 and 1992, was to identify factors associ-
ated with suicidal ideation and attempted suicide
in an Australian sample of HIV-positive and
HIV-negative homosexual and bisexual men.
We hypothesized that suicidal ideation scores
would be significantly higher in those with
symptomatic HIV infection, compared with
those with asymptomatic infection, and that sui-
cidality would be less prevalent among those
who are HIV-negative. We also predicted that
for all groups, suicidal ideation and past suicide
attempt would be associated with the presence
of a psychiatric disorder, assessed in a diagnostic
interview.
METHODS AND SUBJECTS
A convenience sample of HIV-antibody positive
and HIV-negative men was recruited from three
Australian centers. Recruitment was done at di-
verse sites, including hospital and community
clinical facilities (e.g., HIV medical outpatient
clinics), AIDS/HIV support services and agen-
cies, and volunteer organizations. No subjects
were directly recruited from either psychiatric
inpatient or outpatient facilities. This approach
is consistent with that taken in other studies of
psychiatric morbidity in HIV infection.15 Partic-
ipants were not paid. The project was reviewed
by the relevant institutional ethics committees,
and informed consent from the subjects was ob-
tained by research staff at study entry. Exclusion
criteria included failure to give consent, age out-
side the range of 18–65 years, and evidence of
significant central nervous system complications
stemming from HIV (e.g., cerebral opportunistic
infection, AIDS-related tumors such as lym-
phoma, or a diagnosis of HIV Dementia Syn-
drome).
The total sample size was 229 (65 HIV-
negative and 164-HIV positive men). The
HIV-positive group was composed of 74 HIV-
positive men who were asymptomatic (Centers
for Disease Control and Prevention [CDC] Stage
II), 5 men with persistent generalized lymph-
adenopathy (CDC Stage III), and 85 men in
CDC Stage IV of the disease. The mean duration
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since diagnosis of HIV infection was 42.8
months for the HIV-positive sample (range: 1–
114 months). A difference in duration of HIV
infection was detected between the symptomatic
HIV-positive men (mean 5 SD: 48.9 5 26
months) and the asymptomatic HIV-positive
men (mean 5 SD: 36.1 5 24.3 months)
(t43.20, df4157, P40.002).
The study was conducted with the collabo-
ration of the following centers: The University
of Queensland, Department of Psychiatry; The
National Centre for HIV Epidemiology and
Clinical Research, Sydney; St. Vincent’s Hos-
pital, Darlinghurst; and Department of Psychi-
atry, University of Melbourne, Victoria.
1. Measures of Recent
Psychological Functioning and
Lifetime Psychiatric Disorders
Suicidal Ideation Scale and Attempted Suicide.
Recent suicidal ideation was assessed by using
a variable composed of the sum of five suicidal
ideation items from the General Health Ques-
tionnaire (GHQ),16 28-item version, and the
Beck Depression Inventory (BDI).17 These
items included 1) the BDI item with the follow-
ing responses (scores from 0–3): “I don’t have
any thoughts of killing myself,” “I feel I would
be better off dead,” “I have definite plans about
committing suicide,” and “I would kill myself if
I had the chance” and 2) the following GHQ
items (each scored from 0–3): “found that the
thought of taking your own life kept coming into
your mind” (Item 24), “found yourself wishing
you were dead and away from it all” (Item 25),
“felt that life isn’t worth living” (Item 27), and
“thought of the possibility that you might do
away with yourself” (Item 28). The scale was
summed to a total score ranging from 0 to 15.
Through the use of self-report questions, the
participants were also asked to indicate any past
history of suicide attempt, whether they had
more than one suicide attempt in their life, and
the date of their last suicide attempt.
Recent Alcohol and Drug Use. The Short
Canterbury Alcoholism Screening Test18 is a
24-item, self-report instrument that assesses re-
cent alcohol use. Self-report items also assess
past injection drug use.
Psychiatric Disorder. The Diagnostic Inter-
view Schedule–Version III-R (DIS)19 was used
to determine current and lifetime rates of psy-
chiatric disorder, according to DSM-III-R diag-
nostic criteria.20 The following sections of the
DIS were used: affective disorders, anxiety dis-
orders, substance use disorders, schizophrenia
and schizoaffective states, and posttraumatic
stress disorder. The data from the DIS interviews
were entered, checked, and scored by using the
DIS data entry-and-scoring program.
2. Background Psychological Attributes
Eysenck Personality Inventory–Neuroticism
(EPI). The EPI, a 10-item measure of neu-
roticism, was used to measure trait anxiety and
propensity to emotional arousal.21
The Defense Style Questionnaire (DSQ). The
Short-Form DSQ22 (40-item version) was used,
from which three subscales are derived: imma-
ture, neurotic, and mature defense scores.
Locus of Control of Behavior (LCB). The
LCB23 (8-item version) was used to measure
personality vulnerability on a dimension of in-
ternal and external locus of control.
Psychiatric History. Details of medical and
family psychiatric history were asked in self-
report format.
3. HIV Status and
Measures of Disease Factors
All seropositive men were in classified,
according to the Classification System for
HTLV-III/LAV (HTLV: human T-lymphotropic
virus, LAV: lymphadenoapthy-associated virus),
published by the CDC in 1987.24 Two other
measures of HIV-related variables were in-
cluded. First, the subjects were asked about the
total number of HIV physical complaints. The
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participants were asked to indicate whether spe-
cific physical symptoms or complications of
HIV infection had occurred following their di-
agnosis. This set of items included the follow-
ing: weight loss, persistent cough, night sweats,
headaches, swollen lymph glands, oral candida
infection, and respiratory infection and enabled
the listing of other physical symptoms not spec-
ified. Second, clinical data were obtained con-
cerning the specific AIDS-related diagnoses; for
example, diagnosis of specific opportunistic in-
fections such as Kaposi’s sarcoma, which were
scored as a variable representing the total num-
ber of AIDS-related diagnoses.
4. Socioenvironmental Factors
Social Support. The Availability of Attach-
ment subscale items from a self-report version
of the Interview Schedule for Social Interac-
tion25 were used.
Life Events Inventory. A 12-item List of
Threatening Life Experiences26 recorded ad-
verse life experiences in the preceding 4 months.
5. Patterns of Psychological
Adjustment to Disease
The Mental Adjustment to Cancer Scale. The
Mental Adjustment to Cancer Scale27 was mod-
ified for use in HIV infection (Mental Adjust-
ment to HIV Scale: MAHIVS). Instructions and
individual items were modified to address re-
actions to having HIV infection or AIDS. The
scale has been shown to have proven validity
and reliability in cancer populations,27 and its
use in HIV infection has previously been re-
ported.28,29 Each item presents a statement con-
cerning a response to HIV infection/AIDS (e.g.,
“I feel that nothing I can do will make a differ-
ence”) and is scored on a four-point scale rang-
ing from “definitely does not apply to me” to
“definitely does apply to me.” Four MAHIVS
subscales were used in this sample: fighting
spirit, hopelessness/helplessness, minimization,
and personal control of disease (Kelly et al., un-
published data, 1997).
Statistical Analysis
Analyses of the differences between the
groups were done by using crosstabulation for
categorical data and t-tests and analysis of var-
iance (ANOVA) for continuous data (e.g., total
suicidal ideation score). Discriminant function
analysis was conducted to determine which vari-
ables discriminated between particular groups.
Suicidal ideation scores were also analyzed by
categorizing the scores. The high scores (top
25%) (score.3) were compared with the 56%
who reported the absence of any suicidal idea-
tion (total score of 0) to maximize discrimina-
tion of clinically relevant groups. Discriminant
function analysis is used to determine which
variables best discriminate between two or more
groups. The number of discriminant functions
extracted is determined by the number of
groups, minus one or the number of dependent
variables, whichever is the smallest. Two meth-
ods are used to interpret significant discriminant
functions: 1) examininaton of the standardized
coefficients and 2) examination of the discrimi-
nant function variable correlations. The stan-
dardized coefficients provide information on the
relative importance of the variable, whereas the
discriminant functions variable correlations as-
sess the relationship between the variable and
the function score. Variables with high scores on
both indices are deemed significant discrimina-
tors. Statistical significance was set at the level
of P,0.01 (two-tailed) to control for multiple
tests of significance. Data analysis was con-
ducted with the Statistical Package for Social
Sciences.30 At the chosen alpha level (0.01),
sample sizes provided statistical power .0.90 to
detect small-to-moderate group effects (i.e.,
0.30) in ANOVA and chi-square analysis.31
RESULTS
Sociodemographic
Characteristics of the Sample
Seventy-seven percent (77%) of the partic-
ipants described themselves as exclusively ho-
mosexual, 19.5% as predominantly homosexual,
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and 3.4% as bisexual. No differences in sexual
identity were detected between the HIV-positive
and HIV-negative individuals (v241.22, NS).
The median age of the sample was 33 years
(range: 20–60 yrs), and there was a significant
age difference across subgroups (mean 5 SD
HIV seronegative: 33.258.8, mean 5 SD CDC
Stage III: 34.258.2, mean 5 SD CDC Stage
IV: 37.558.7; F(2,226)45.43, P40.005).
Eighty-four percent of the sample were born in
either Australia or New Zealand. Employment
rates varied significantly among the groups, with
81% of the HIV-negative men currently in full-
or part-time employment, compared with 72%
of the HIV-positive men (CDC Stage II/III) and
44% of the men in the HIV-positive (CDC Stage
IV) group (v2419.78, df42, P,0.001). The
participants were a predominantly well-educated
group, with 70% having at least 12 years of edu-
cation, which included 30% who had a tertiary
qualification. No differences in educational level
were detected among the groups (v243.5,
df42, P.0.1).
Suicidal Ideation
The suicidal ideation items exhibited a high
level of internal reliability (Cronbach’s al-
pha40.89). Total scores obtained on this sui-
cidal ideation scale ranged from 0–14, with a
mean of 1.8 (SD43.0). The total suicidal idea-
tion scores were significantly higher in the HIV-
positive group (mean 5 SD: 2.253.3) than in
the HIV-negative group (mean 5 SD: 0.951.6)
(t412.62, df4189, P,0.01). Significant dif-
ferences in total suicidal ideation score were also
detected between the HIV-negative men
(mean 5 SD: 0.951.6), CDC Stage II/III men
(mean 5 SD: 1.853.0), and CDC Stage IV
men (mean 5 SD: 2.653.6) (F(2,190)44.71,
P,0.01). Tukey HSD (honest significant differ-
ence) post hoc analysis revealed statistically sig-
nificant differences between the CDC Stage IV
and HIV-negative groups (P,0.01).
Current and Lifetime Psychiatric
Disorder and Suicidal Ideation
A comparison of suicidal ideation scores
was made across the most frequent psychiatric
diagnoses: major depression, anxiety disorder
(panic disorder or generalized anxiety disorder),
and substance abuse/dependence. One-way
ANOVA was conducted by comparing those
with no lifetime history of a diagnosis, those
with a positive lifetime diagnosis (but no current
6-month diagnosis), and those with a current di-
agnosis (6 month). Suicidal ideation scores were
significantly higher among the individuals with
current (6 month) major depression diagnosis
(n436, mean 5 SD: 4.354.6) than those with
a lifetime history of major depression (but no
current major depression) (n439)
(mean 5 SD: 1.5 5 2.5) and those with no life
lifetime or current major depression (n4145)
(mean 5 SD: 1.4 5 2.3) (F(2,182)412.70,
P,0.0001). A similar pattern was detected for
current anxiety diagnoses, with suicidal ideation
scores significantly higher in the current diag-
nosis group (n413) (mean 5 SD: 5.8 5 5.2)
than both other groups (lifetime but no current
disorder (n411) (mean 5 SD: 1.7 5 2.5) and
no lifetime disorder (n4193) (mean 5 SD:
1.6 5 2.7) (F(2,180)49.97, P,0.001). No differ-
ences were detected in suicidal ideation scores,
according to the presence of a current diagnosis
of substance abuse/dependence (F(2,116)42.66,
P40.07).
Rates of Past Suicide Attempt
Lifetime rates of attempted suicide were
29.1% for the HIV-negative men and 21.4% for
the HIV-positive men (v241.29, df41,
P40.26). No significant differences in rates of
attempted suicide were found, according to CDC
classification: CDC Stage II/III 24.6%, CDC
Stage IV 18.3% (v242.07, df42, P40.36). Of
those men who had a history of suicide attempts,
the following rates of multiple (i.e., more than
one) suicide attempt were reported: HIV-nega-
tive 66.7%, CDC Stage II/III 50%, and CDC
Stage IV 61.5% (v240.94, df42, P40.63).
Discriminant Function Analysis:
High and Low Suicidal Ideation
A series of discriminant function analyses
was done to determine the variables that dis-
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TABLE 2. Discriminant function analysis: high and low suicide ideation scores (HIV-positive group only)
Variable Standardized Coefficient Discriminant Function-Variable Correlations
Number of AIDS diagnoses 0.33 0.32
MAHIVS Hopelessness 0.62 0.88
MAHIVS Fighting Spirit 10.24 10.42
Neuroticism 0.41 0.59
Note: HIV4human immunodeficiency virus; AIDS4acquired immunodeficiency syndrome. MAHIVS4Mental Ad-
justment to HIV Scale. Canonical correlation40.65. Chi-square456.02, df44, P,0.0001. Centroids: Group 1 (low
suicidal ideation scorers)410.65. Group 2 (high suicidal ideation scorers)41.12.
TABLE 1. Discriminant factor analysis: high and low suicide ideation scores (total sample)
Variable Standardized Coefficient Discriminant Function-Variable Coefficients
External locus of control 0.45 0.46
Neuroticism 0.52 0.67
Any current psychiatric diagnosis 0.28 0.49
Employment status 10.43 10.51
HIV status 0.31 0.27
Note: HIV4human immunodeficiency virus. Canonical correlation40.77. Chi-square434.74, df45, P,0.0001.
Centroids: Group 1 (low suicidal ideation scorers)410.37, Group 2 (high suicidal ideation scorers)40.79.
criminated between those with high and low sui-
cidal ideation scores (Table 1 and Table 2). The
first analysis was done by using the total sample
of HIV-negative and HIV-positive individuals to
assess the independent influence of HIV status
on suicidal ideation. The second analysis was
conducted by using the HIV-positive group only,
which enabled investigation of variables specific
to this group (e.g., adaptation to HIV diagnosis
and severity of disease).
In the total group (Table 1), a significant
discriminant function was detected, which con-
tained the following variables (figures given are
standardized correlation coefficient values), dis-
criminating for higher suicidal ideation scores:
higher EPI–neuroticism scores (0.52), external
locus of control scores (0.45), current unem-
ployment (10.43), HIV-positive status (0.31),
and the presence of any current (6 month) psy-
chiatric disorder (0.28) (Canonical correla-
tion40.77, v2434.74, df45, P,0.001).
In the analysis of the HIV-positive group
alone (Table 2), a significant discriminant func-
tion was detected, which contained the follow-
ing variables: higher MAHIVS hopelessness
subscale (0.62), higher EPI–neuroticism scores
(0.41), the greater number of current AIDS-
related diagnoses (0.33), and lower MAHIVS
fighting-spirit subscale (10.24) (Canonical cor-
relation40.65, v2456.02, df44, P,0.001).
Discriminant Function Analysis:
Attempted Suicide vs. No Past
Attempted Suicide
A set of discriminant function analyses was
done to determine the variables that discrimi-
nated for the presence of a lifetime history of
attempted suicide (Table 3). These analyses
were first conducted with the inclusion of de-
pression diagnoses. In the total group, the sig-
nificant discriminators were a positive lifetime
diagnosis of dysthymic disorder (0.56), a posi-
tive lifetime diagnosis of major depression
(0.46), DSQ–immature defense score (0.43), and
DSQ–neurotic defense score (0.32) (Canonical
correlation40.38, v2426.25, df44, P,
0.0001) (Centroids: no history410.24, posi-
tive history of attempted suicide40.71).
In the separate analysis of the HIV-positive
Kelly et al.
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group only, the significant discriminators for a
lifetime history of suicide attempt were a posi-
tive lifetime history of injection drug use (0.73),
external locus of control (0.46), a positive family
history of suicide attempt (0.41), and a positive
lifetime history of major depression (0.26) (Ca-
nonical correlation40.40, v2420.00, df44,
P,0.001) (Centroids: no history410.22, posi-
tive history of attempted suicide40.88).
Another discriminant function analysis was
done, but this time with depression diagnoses
excluded because the presence of a history of
attempted suicide is an item included in the DIS
for the diagnosis of major depression. In the total
group, the following variables discriminated for
the presence of a history of attempted suicide: a
lifetime history of injection drug use (0.47),
higher DSQ–neurotic defense scale scores
(0.44), higher scores on the DSQ–immature de-
fense scale (0.44), a positive family history of
attempted suicide (0.36), and HIV serostatus
(10.35) (i.e., being HIV-negative) (Canonical
correlation40.32, v2416.72, df45, P,0.01)
(Centroids: no history410.18, positive history
of attempted suicide40.63). In the HIV-positive
group, the following variables contributed to a
significant discriminant function: a positive life-
time history of injection drug use (0.69), DSQ–
immature defense score (0.43), a positive family
history of attempted suicide (0.34), and external
locus of control (0.31) (Canonical correla-
tion40.42, v2422.21, df44, P,0.001) (Cen-
troids: no history410.23, positive history of
attempted suicide40.93).
DISCUSSION
The aim of this study was to examine current
suicidal ideation and past suicide attempt as di-
mensions of psychological morbidity in HIV in-
fection. Significantly higher total suicidal idea-
tion scores were present in the CDC Stage IV
group, compared with the HIV-negative group,
but the former’s scores were not significantly
higher than the HIV-positive CDC Stage II/III
group. Multivariate analyses indicated signifi-
cant independent effects of the following vari-
ables on suicidal ideation scores in the total sam-
ple: personality measures (external locus of
control and neuroticism), psychiatric disorder
(the presence of current psychiatric disorder),
disease factors (being HIV-positive), and social
factors (being unemployed).
Among the HIV-positive men, when ana-
lyzed separately, psychiatric disorder was not a
significant discriminator of high suicidal idea-
tion scores, yet the number of current AIDS di-
agnoses (and therefore the possible burden of
disease), a greater level of hopelessness, and
lower fighting spirit scores, along with higher
neuroticism scores, were significant. These find-
ings suggest that the severity of HIV disease and
patterns of psychological adaptation to disease
(lower level of perceived control, greater hope-
lessness), along with premorbid attributes (e.g.,
neuroticism), represent the chief discriminators
of suicidal ideation in the HIV-positive group.
The salience of hopelessness as a discriminator
for suicidal ideation is consistent with existing
literature in community samples and medically
ill populations.32,33 Psychiatric disorder may
have failed to discriminate for high suicidal ide-
ation scores because of the more powerful role
of coexisting hopelessness.
High rates of past suicide attempt were de-
tected in this population (18%–30%), similar to
those rates reported from other studies of HIV-
positive populations.12 The consistent predictor
of attempted suicide remained a positive lifetime
history of a psychiatric disorder. The findings
also suggest a link between psychiatric disorder
(particularly depression diagnosis), lifetime his-
tory of injection drug use, psychological adjust-
ment patterns (e.g., DSQ and LCB), and family
history of attempted suicide. The significant role
of HIV-negative status as a discriminating factor
for a lifetime history of suicide attempt may in-
dicate the effect of recruitment bias or perhaps
an effect of fear of acquiring HIV infection.
In the HIV-positive men, there was no sig-
nificant association between past suicide attempt
and the number of HIV physical symptoms or
CDC classification. This finding suggests that
these indices of disease severity were far less
influential on suicide attempts in the HIV-
positive individuals than the presence of psy-
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chiatric disorder (particularly major depression)
and patterns of psychological adaptation (DSQ
scores and family history).
The findings support the dimensional nature
of suicidal behavior, with suicide attempts
closely associated with the presence of a psy-
chiatric disorder, whereas current suicidal idea-
tion demonstrates a stronger association with
hopelessness in response to the current impact
of HIV infection and is associated with a range
of adaptational, personality, and social factors.
Study limitations include the potential bias
in a convenience sample, although it has been
argued that it is difficult to establish the repre-
sentativeness of selected samples of homosex-
ual/bisexual men.34 The study also did not in-
clude women; therefore, the generalizations
from this sample to broader populations of in-
dividuals with HIV infection are limited.
The measure for suicidal ideation was de-
rived from the GHQ and BDI, similar to meth-
ods used in other studies of HIV infection3,12 and
general community,35 but may have limited our
focus to the most overt forms of suicidal idea-
tion. Other issues concern the potential intercor-
relations among hopelessness, suicidal ideation,
past attempted suicide, and depression diagno-
ses, as items used to measure one variable (e.g.,
hopelessness) may also be incorporated into
items or criteria for other key variables (e.g., the
presence of major depression). Past suicide at-
tempts and suicidal ideation are included in the
DIS major depression items and criteria. The use
of separate measures of past history of attempted
suicide, current suicidal ideation (e.g., a com-
posite self-report measure), and the DIS for psy-
chiatric diagnosis provides a relatively indepen-
dent set of measures of suicidal ideation and
psychiatric disorder. The findings of this study
also need to be interpreted alongside the recent
advances in the treatment of HIV infection,
namely therapy with multiple protease inhibi-
tors.36 This study was done before the wide-
spread use of such treatments; therefore, the
more recent impact of these newer treatments,
the prospects of longer term survival with HIV
infection, and the effects of these developments
on psychological morbidity need to be consid-
ered.36 Many HIV-positive individuals also par-
ticipate in trials of new treatment modalities.
The influence of the participation in such clinical
trials on the levels of psychological symptoms
and suicidal ideation was not addressed among
our participants.
CONCLUSION
The findings in this study are consistent with the
other published findings from studies addressing
suicidal ideation and attempted suicide in indi-
viduals with HIV infection.9–13 Suicidal ideation
and attempted suicide were found to be associ-
ated with a family history of attempted suicide,
drug use, and psychiatric disorder.
Patterns of adaptation to disease and ap-
praisal of HIV infection, other than disease se-
verity alone, represent significant predictors of
suicidal ideation in this group of HIV-positive
gay men. Greater levels of fighting spirit, a spe-
cific pattern of adjustment to disease such as
HIV infection, were linked with lower levels of
suicidal ideation, further supporting the poten-
tial protective role of such responses against
psychological morbidity in the face of a life-
threatening illness, which has not been previ-
ously reported in association with suicidal ide-
ation. Therefore, these findings provide a basis
for improving clinical knowledge about the fac-
tors that may increase suicidal ideation and risk
of suicide in HIV-positive and HIV-negative
men, highlight the need for careful screening for
suicidal risk and suicidal ideation by HIV clini-
cal services, and emphasize the important role
of psychiatric assessment and liaison.3 It is im-
portant that further research assess the impact of
treatment improvements and newer therapies for
HIV/AIDS on indicators of psychological mor-
bidity, such as suicidal ideation and suicidal be-
haviors, in this patient population.
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